Skip to main
CNC

Centene (CNC) Stock Forecast & Price Target

Centene (CNC) Analyst Ratings

Based on 15 analyst ratings
Hold
Strong Buy 7%
Buy 20%
Hold 60%
Sell 7%
Strong Sell 7%

Bulls say

Centene has demonstrated a solid financial foundation, highlighted by a year-over-year improvement in its Medicaid Health Benefit Ratio (HBR) to 93.4%, indicating effective cost management and operational efficiency. The company's expansion in membership within 3.5+ Star plans to 60% enhances its competitive positioning and revenue potential, while a composite rate improvement expectation of approximately 5.5% signifies positive revenue momentum. Additionally, the firm's Medicare and Prescription Drug Plan (PDP) memberships exceeded expectations, further indicating strong market demand and operational performance.

Bears say

Centene's management anticipates a significant decrease in its portfolio allocation to low-cost Silver positions, dropping from 55% in 2025 to 42% in 2026, which may adversely affect revenue stability in the coming years. Additionally, the company has indicated a pre-tax earnings impact of approximately $2.4 billion for fiscal year 2025, driven by risk adjustment revisions that are projected to be $1.8 billion to $2.75 billion lower than prior estimates. Concerns regarding the deterioration of Marketplace risk scores and ongoing pressures on Medicaid margins further exacerbate the negative outlook for Centene’s financial performance.

Centene (CNC) has been analyzed by 15 analysts, with a consensus rating of Hold. 7% of analysts recommend a Strong Buy, 20% recommend Buy, 60% suggest Holding, 7% advise Selling, and 7% predict a Strong Sell.

This aggregate rating is based on analysts' research of Centene and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Centene (CNC) Forecast

Analysts have given Centene (CNC) a Hold based on their latest research and market trends.

According to 15 analysts, Centene (CNC) has a Hold consensus rating as of Feb 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $41.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $41.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Centene (CNC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.